Hildebrandt G, Seed M P, Freemantle C N, Alam C A, Colville-Nash P R, Trott K R
Klinik für Strahlentherapie und Radioonkologie, Universität Leipzig, Germany.
Strahlenther Onkol. 1998 Nov;174(11):580-8. doi: 10.1007/BF03038296.
Substantial clinical evidence shows the efficacy of low-dose radiotherapy in the treatment of a wide variety of benign conditions. However, experimental investigations into these empirically clinical observations remain scarce. We investigated in vivo low-dose radiation effects on chronic granulomatous tissue by using the air pouch model in mice.
Chronic granulomatous air pouches were induced in mice and dosed according to 4 protocols: group I: sham control; group II: 2 Gy on day 2; group III: 2 Gy on day 6; group IV: 5 daily doses of 0.5 Gy from day 2 to 6. On day 7 after granuloma induction the granuloma wet and dry weight was estimated, the vascular content was assessed by the formation of vascular casts incorporating carmine, the inducible nitric oxide synthase (iNOS)- and heme oxygenase 1 (HO-1)-expression in tissue homogenates was assessed by Western blot analysis, and the immunohistochemical localization of iNOS was carried out in cryostat sections of the granulomatous tissue.
We did not observe any significant reduction in granulomatous tissue wet weight or dry weight following the different radiation treatments, which indicates that anti-proliferative effects in response to the low radiation doses used, are probably not involved in the effects of anti-inflammatory radiotherapy. A single dose of 2 Gy on day 2, as well as fractionated treatment with 5 x 0.5 Gy lead to an increase in vascularity. iNOS-expression in the homogenized granulomatous tissue was decreased, being most pronounced after single-dose irradiation with 2 Gy on day 2, early on in the acute phase of inflammation. In contrast, the HO-1-expression was increased in all irradiated groups.
Low doses of radiation interfere with the NO- and the HO-1 pathway. Since NO contributes to several aspects of inflammation such as oedema formation and inflammatory pain, we put forward the hypothesis, that the inhibitory effect of low doses of ionizing radiation on the NO pathway is one radiobiological mechanism underlying the clinically observed efficacy of anti-inflammatory radiotherapy and might result in the reduction of swelling as well as relief of pain. Furthermore, the suppression of iNOS activity could be due to the increase in the stress protein HO-1 by low dose radiotherapy.
大量临床证据表明低剂量放疗在治疗多种良性疾病方面具有疗效。然而,针对这些基于经验的临床观察的实验研究仍然很少。我们通过在小鼠中使用气袋模型研究了体内低剂量辐射对慢性肉芽肿组织的影响。
在小鼠中诱导慢性肉芽肿气袋,并根据4种方案给药:第一组:假对照;第二组:在第2天给予2 Gy;第三组:在第6天给予2 Gy;第四组:从第2天至第6天每天给予5次0.5 Gy。在诱导肉芽肿后第7天,估计肉芽肿的湿重和干重,通过包含胭脂红的血管铸型形成评估血管含量,通过蛋白质免疫印迹分析评估组织匀浆中诱导型一氧化氮合酶(iNOS)和血红素加氧酶1(HO-1)的表达,并在肉芽肿组织的低温切片中进行iNOS的免疫组织化学定位。
在不同的辐射处理后,我们未观察到肉芽肿组织湿重或干重有任何显著降低,这表明针对所用低辐射剂量的抗增殖作用可能与抗炎放疗的效果无关。在第2天给予单次2 Gy剂量以及采用5×0.5 Gy的分次治疗均导致血管生成增加。在匀浆的肉芽肿组织中,iNOS表达降低,在炎症急性期早期,于第2天给予单次2 Gy照射后最为明显。相比之下,所有照射组中的HO-1表达均增加。
低剂量辐射干扰NO和HO-1途径。由于NO在炎症的多个方面发挥作用,如水肿形成和炎性疼痛,我们提出假说,即低剂量电离辐射对NO途径的抑制作用是抗炎放疗临床观察到的疗效背后的一种放射生物学机制,可能导致肿胀减轻和疼痛缓解。此外,低剂量放疗导致应激蛋白HO-1增加可能是iNOS活性受到抑制的原因。